Seminar

TWINCORE Seminar - Systems Immunology

Dr. Verónica Durán
Stanford University School of Medicine, Stanford

"Age-dependent immune landscape in dengue infection and disease progression"

---
Prof. Shirit Einav
Stanford University School of Medicine, Stanford

"Targeting an understudied lipid kinase to restore lysosomal function in viral infection and neurodegeneration"

Event information
  •  – 
  • TWINCORE Seminar Room 0020

Speakers:

Dr. Verónica Durán

Dr. Verónica Durán

Stanford University School of Medicine, Stanford

Prof. Shirit Einav

Prof. Shirit Einav

Stanford University School of Medicine, Stanford

Abstracts:

Dr. Veronica Durán

Age-dependent immune landscape in dengue infection and disease progression

Dengue lacks approved treatments and shows unpredictable outcomes due to unclear immune determinants. Using systems immunology, integrating single-cell transcriptomics, functional experiments, and plasma proteomics, we investigate how age influences immune responses during acute infection in individuals who resolve or develop severe dengue. We identify age-dependent differences in interferon, NF-κB, antigen presentation, and regulatory pathways, revealing that immune setpoints across the lifespan determine disease trajectories.

Prof. Shirit Einav

Targeting an understudied lipid kinase to restore lysosomal function in viral infection and neurodegeneration

We identified the lipid kinase PIP4K2C as a negative regulator of lysosomal function. Its inhibition restores lysosomal acidification and proteolysis via phosphoinositide remodeling on lysosomal membranes and TFEB activation. We discovered that viruses like SARS-CoV-2 bind PIP4K2C to arrest autophagic flux and evade their own degradation, and that inhibiting it exerts broad antiviral activity. Applying this strategy to neurodegeneration, we found that targeting PIP4K2C also rescues key phenotypes of Amyotrophic lateral sclerosis and Parkinson’s disease. These results uncover new mechanisms of lysosomal regulation and establish PIP4K2C as a druggable target for lysosomal restoration across pathologies.

Host:

Ulrich Kalinke

Ulrich Kalinke

Executive Director

+49 (0)511-220027-111twincore@twincore.de